Your browser doesn't support javascript.
loading
Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.
Deedwania, P C; Shepherd, J; Breazna, A; DeMicco, D A.
Affiliation
  • Deedwania PC; UCSF School of Medicine, Fresno, CA, USA.
  • Shepherd J; University of Glasgow, Glasgow, UK.
  • Breazna A; Pfizer Inc, New York, NY, USA.
  • DeMicco DA; Pfizer Inc, New York, NY, USA.
Diabetes Obes Metab ; 18(1): 56-63, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26434404
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Metabolic Syndrome / Atorvastatin / Cholesterol, LDL / Anticholesteremic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2016 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Metabolic Syndrome / Atorvastatin / Cholesterol, LDL / Anticholesteremic Agents Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2016 Document type: Article Affiliation country: Estados Unidos